MARKET

CNCR

CNCR

Range Cancer Therapeutics ETF
NASDAQ
12.30
-0.21
-1.68%
Closed 11:58 02/07 EST
OPEN
12.65
PREV CLOSE
12.51
HIGH
12.65
LOW
12.30
VOLUME
2.15K
TURNOVER
--
52 WEEK HIGH
17.96
52 WEEK LOW
11.38
TOTAL ASSET
9.80M
YTD YIELD
-17.01%
1D
5D
1M
3M
1Y
5Y
1D
J.P. Morgan Healthcare Conference 2025: Healthcare's Roadmap For The Year Ahead
Seeking Alpha · 2d ago
Weekly Report: what happened at CNCR last week (0127-0131)?
Weekly Report · 4d ago
From Underperformance To Opportunity: Biotech's Case For 2025
Seeking Alpha · 01/29 11:30
Tech-Enabled Health: Revolutionizing The Standard Of Care
Seeking Alpha · 01/27 10:50
Weekly Report: what happened at CNCR last week (0120-0124)?
Weekly Report · 01/27 10:47
Weekly Report: what happened at CNCR last week (0113-0117)?
Weekly Report · 01/20 10:40
U.S. Public Energy Companies Record Highest Median Default Risk At 2024-End
Seeking Alpha · 01/16 15:00
Weekly Report: what happened at CNCR last week (0106-0110)?
Weekly Report · 01/13 10:41
More
Profile
Fund Name
Range Cancer Therapeutics ETF
Inception Date
2015-10-13
Benchmark
Loncar Cancer Immunotherapy TR USD
Advisor Company
Range Cancer
Custodian
U.S. Bank N.A
Manager
Rafael Zayas, Austin Wen, Andrew Serowik, Gabriel Tan, Todd Alberico, Brian Cooper